ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
18.95
+0.38 (2.05%)
At close: Mar 28, 2025, 4:00 PM
18.67
-0.28 (-1.50%)
After-hours: Mar 28, 2025, 5:16 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $644.61 million as of March 28, 2025. Its market cap has decreased by -2.32% in one year.
Market Cap
644.61M
Enterprise Value
425.92M
1-Year Change
-2.32%
Ranking
Category
Stock Price
$18.95
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $644.61M, an increase of 12.06%. That is a compound annual growth rate of 10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 644.61M | -28.19% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |